Registration No. 333-______

                       SECURITIES AND EXCHANGE COMMISSION
                                Washington, D.C.

                                    FORM S-8

                          REGISTRATION STATEMENT UNDER
                           THE SECURITIES ACT OF 1933


                                VASOMEDICAL, INC.
             (Exact name of registrant as specified in its charter)

           Delaware                                  11-2871434
(State or other jurisdiction of           (IRS Employer Identification No.)
 incorporation or organization)

        180 Linden Avenue, Westbury, New York          11590
      (Address of principal executive offices)       (Zip Code)

              VASOMEDICAL, INC. 1999 STOCK OPTION PLAN, AS AMENDED
                            (Full title of the plan)

                          D. Michael Deignan, President
                                Vasomedical, Inc.
                                180 Linden Avenue
                            Westbury, New York 11590
                     (Name and address of agent for service)

                                 (516) 997-4600
          (Telephone number, including area code, of agent for service)

                                    copy to:
                            David H. Lieberman, Esq.
                     Blau, Kramer, Wactlar & Lieberman, P.C.
                             100 Jericho Quadrangle
                             Jericho, New York 11753
                                 (516) 822-4820


                         CALCULATION OF REGISTRATION FEE

<TABLE>
<CAPTION>
                                             Proposed maximum    Proposed maximum
Title of securities    Amount to be          offering price      aggregate offering     Amount of
to be registered       Registered (1)        per security (2)       price (2)        registration fee
------------------------------------------------------------------------------------------------------
<S>                  <C>                          <C>              <C>                    <C>
Common Stock,
par value $.001
per share            1,000,000 shs. (3)(4)        $4.50             $4,500,000             $1,251


(1)  The Registration statement also covers an indeterminate number of shares of
     Common  Stock  which may become  issuable  pursuant  to  anti-dilution  and
     adjustment provisions of the plan.
(2)  Estimated solely for the purpose of calculating the registration fee, based
     upon the average of the high and low prices of the  Company's  Common Stock
     reported on Nasdaq on July 24, 2000, pursuant to Rule 457.
(3)  Represents   additional   shares  of  Common  Stock   issuable   under  the
     Vasomedical, Inc. 1999 Stock Option Plan, as amended.
(4)  Pursuant to Rule 457, a registration  fee of $1,251 is payable with respect
     to the  additional  1,000,000  shares of Common  Stock  issuable  under the
     Vasomedical, Inc. 1999 Stock Option Plan, as amended.

</TABLE>

<PAGE>

                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.   Incorporation of Documents by Reference.

          This Registration  Statement on Form S-8 is being filed to register an
additional  1,000,000  shares of Common Stock  available for issuance  under the
Registrant's  1999 Stock  Option  Plan,  as  amended.  An  initial  Registration
Statement on Form S-8  (Registration  Statement No.  333-85457)  was  previously
filed with  respect to that plan.  The  contents  of such  earlier  Registration
Statement No. 333-85457 are hereby incorporated by reference.

          All documents filed pursuant to Sections 13(a), 13(c), 14 and 15(d) of
the  Securities  Exchange  Act of 1934  after  the  date  of  this  Registration
Statement and prior to the termination of this offering of Common Stock shall be
deemed to be incorporated by reference in this Registration  Statement and to be
a part hereof from the date of filing of such documents. Any statement contained
in a document  incorporated  or deemed to be  incorporated  by reference in this
Registration Statement shall be deemed to be modified or superseded for purposes
of this Registration  Statement to the extent that a statement  contained herein
or  in  any  subsequently  filed  document  that  also  is or  is  deemed  to be
incorporated by reference  herein  modifies or supercedes  such  statement.  Any
statement so modified or superseded  shall not be deemed,  except as so modified
or superseded, to constitute a part of this Registration Statement.

          The Company will provide  without charge to each person to whom a copy
of this Registration Statement is delivered, upon the written or oral request of
such person,  a copy of any or all of the  documents  incorporated  by reference
(except for  exhibits  thereto  unless  specifically  incorporated  by reference
therein).  Requests  for  such  copies  should  be  directed  to the  Secretary,
Vasomedical,  Inc., 180 Linden Avenue,  Westbury, New York 11590, (516) 997-4600
ext.790.

Item 8.   Exhibits.

          4    1999 Stock Option Plan, as amended

          5    Opinion and consent of Blau, Kramer, Wactlar & Lieberman, P.C.

          23.1 Consent of Blau, Kramer, Wactlar & Lieberman,  P.C. - included in
               their opinion filed as Exhibit 5

          23.2 Consent of Grant Thornton LLP

          24   Power of Attorney included in signature page hereof

<PAGE>

                                   SIGNATURES

      Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement to be signed on its behalf thereunto duly authorized, in Westbury, New
York on the 31st day of July, 2000.

                              VASOMEDICAL, INC.
                              By: /s/ D. Michael Deignan
                              --------------------------------------------
                              D. Michael Deignan, President and Chief Executive
                              Officer and Director (Principal Executive Officer)

                                POWER OF ATTORNEY

      KNOW ALL MEN BY THESE PRESENTS,  that each person whose signature  appears
below  constitutes and appoints D. Michael Deignan and Joseph A. Giacalone,  and
each of them, his true and lawful  attorneys-in-fact and agents, with full power
of substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to sign any and all amendments (including post-effective
amendments)  to this  Registration  Statement  and to file  the  same,  with all
exhibits  thereto,  and  other  documents  in  connection  therewith,  with  the
Securities and Exchange  Commission,  granting unto said  attorneys-in-fact  and
agents,  and each of them,  full power and  authority to do and perform each and
every act and thing  requisite and necessary to be done, as fully to all intents
and purposes as he might or could do in person,  hereby ratifying and confirming
all that  said  attorneys-in-fact  and  agents  or any of them,  or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

      In accordance  with the  requirements  of the Securities Act of 1933, this
registration  statement  was signed by the following  persons in the  capacities
indicated on July 31, 2000.

         Signatures                            Title
         ----------                            -----

-----------------------------           Director
Alexander G. Bearn


/s/ David S. Blumenthal                 Director
-----------------------------
David S. Blumenthal

/s/ Abraham E. Cohen                    Chairman of the Board
-----------------------------
Abraham E. Cohen

/s/ D. Michael Deignan
-----------------------------           President, Chief Executive Officer and
D. Michael Deignan                      Director (Principal Executive Officer)

/s/ Joseph A. Giacalone
-----------------------------           Secretary and Chief Financial Officer
Joseph A. Giacalone                     (Principal Financial and Accounting
                                        Officer)

/s/ John C.K. Hui                       Director
-----------------------------
John C. K. Hui


-----------------------------           Director
Photios T. Paulson


/s/ Kenneth W. Rind                     Director
-----------------------------
Kenneth W. Rind

/s/ E. Donald Shapiro                   Director
-----------------------------
E. Donald Shapiro

/s/ Anthony Viscusi                     Director
-----------------------------
Anthony Viscusi

/s/ Forrest R. Whittaker                Director
-----------------------------
Forrest R. Whittaker

/s/ Zhen-sheng Zheng                    Director
-----------------------------
Zhen-sheng Zheng

<PAGE>

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549




                                Vasomedical, Inc.





                         Form S-8 Registration Statement

                             E X H I B I T  I N D E X


                                                      Page No. in Sequential
Exhibit                                               Numbering of all Pages,
Number              Exhibit Description               including Exhibit Pages
------------------------------------------------------------------------------

4             1999 Stock Option Plan, as amended

5             Opinion and Consent of Counsel

23.1          Consent of Counsel                        See Exhibit 5

23.2          Consent of Grant Thornton LLP

24            Power of Attorney                         See signature page
[{"type": "S-8", "sequence": "1", "filename": "0001.txt", "secsgml_size_bytes": 9911}]
{"company-data": {"conformed-name": "VASOMEDICAL INC", "cik": "0000839087", "assigned-sic": "3845", "irs-number": "112871434", "state-of-incorporation": "DE", "fiscal-year-end": "0531"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-42692", "film-number": "682986"}, "business-address": {"street1": "180 LINDEN AVENUE", "city": "WESTBURY", "state": "NY", "zip": "11590", "phone": "5169974600"}, "mail-address": {"street1": "150 MOTOR PARKWAY", "street2": "SUITE 408", "city": "HAUPPAUGE", "state": "NY", "zip": "11788"}, "former-company": [{"former-conformed-name": "FUTURE MEDICAL PRODUCTS INC /DE/", "date-changed": "19920703"}, {"former-conformed-name": "FUTURE MEDICAL PRODUCTS INC /NY/", "date-changed": "19920506"}]}
Registration No. 333-______

                       SECURITIES AND EXCHANGE COMMISSION
                                Washington, D.C.

                                    FORM S-8

                          REGISTRATION STATEMENT UNDER
                           THE SECURITIES ACT OF 1933

                                VASOMEDICAL, INC.
             (Exact name of registrant as specified in its charter)

           Delaware                                  11-2871434
(State or other jurisdiction of           (IRS Employer Identification No.)
 incorporation or organization)

        180 Linden Avenue, Westbury, New York          11590
      (Address of principal executive offices)       (Zip Code)

              VASOMEDICAL, INC. 1999 STOCK OPTION PLAN, AS AMENDED
                            (Full title of the plan)

                          D. Michael Deignan, President
                                Vasomedical, Inc.
                                180 Linden Avenue
                            Westbury, New York 11590
                     (Name and address of agent for service)

                                 (516) 997-4600
          (Telephone number, including area code, of agent for service)

                                    copy to:
                            David H. Lieberman, Esq.
                     Blau, Kramer, Wactlar & Lieberman, P.C.
                             100 Jericho Quadrangle
                             Jericho, New York 11753
                                 (516) 822-4820

                         CALCULATION OF REGISTRATION FEE
Proposed maximum    Proposed maximum
Title of securities    Amount to be          offering price      aggregate offering     Amount of
to be registered       Registered (1)        per security (2)       price (2)        registration fee
------------------------------------------------------------------------------------------------------
Common Stock,
par value $.001
per share            1,000,000 shs. (3)(4)        $4.50             $4,500,000             $1,251

(1)  The Registration statement also covers an indeterminate number of shares of
     Common  Stock  which may become  issuable  pursuant  to  anti-dilution  and
     adjustment provisions of the plan.
(2)  Estimated solely for the purpose of calculating the registration fee, based
     upon the average of the high and low prices of the  Company's  Common Stock
     reported on Nasdaq on July 24, 2000, pursuant to Rule 457.
(3)  Represents   additional   shares  of  Common  Stock   issuable   under  the
     Vasomedical, Inc. 1999 Stock Option Plan, as amended.
(4)  Pursuant to Rule 457, a registration  fee of $1,251 is payable with respect
     to the  additional  1,000,000  shares of Common  Stock  issuable  under the
     Vasomedical, Inc. 1999 Stock Option Plan, as amended.
PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.   Incorporation of Documents by Reference.

          This Registration  Statement on Form S-8 is being filed to register an
additional  1,000,000  shares of Common Stock  available for issuance  under the
Registrant's  1999 Stock  Option  Plan,  as  amended.  An  initial  Registration
Statement on Form S-8  (Registration  Statement No.  333-85457)  was  previously
filed with  respect to that plan.  The  contents  of such  earlier  Registration
Statement No. 333-85457 are hereby incorporated by reference.

          All documents filed pursuant to Sections 13(a), 13(c), 14 and 15(d) of
the  Securities  Exchange  Act of 1934  after  the  date  of  this  Registration
Statement and prior to the termination of this offering of Common Stock shall be
deemed to be incorporated by reference in this Registration  Statement and to be
a part hereof from the date of filing of such documents. Any statement contained
in a document  incorporated  or deemed to be  incorporated  by reference in this
Registration Statement shall be deemed to be modified or superseded for purposes
of this Registration  Statement to the extent that a statement  contained herein
or  in  any  subsequently  filed  document  that  also  is or  is  deemed  to be
incorporated by reference  herein  modifies or supercedes  such  statement.  Any
statement so modified or superseded  shall not be deemed,  except as so modified
or superseded, to constitute a part of this Registration Statement.

          The Company will provide  without charge to each person to whom a copy
of this Registration Statement is delivered, upon the written or oral request of
such person,  a copy of any or all of the  documents  incorporated  by reference
(except for  exhibits  thereto  unless  specifically  incorporated  by reference
therein).  Requests  for  such  copies  should  be  directed  to the  Secretary,
Vasomedical,  Inc., 180 Linden Avenue,  Westbury, New York 11590, (516) 997-4600
ext.790.

Item 8.   Exhibits.

          4    1999 Stock Option Plan, as amended

          5    Opinion and consent of Blau, Kramer, Wactlar & Lieberman, P.C.

          23.1 Consent of Blau, Kramer, Wactlar & Lieberman,  P.C. - included in
               their opinion filed as Exhibit 5

          23.2 Consent of Grant Thornton LLP

          24   Power of Attorney included in signature page hereof
SIGNATURES

      Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement to be signed on its behalf thereunto duly authorized, in Westbury, New
York on the 31st day of July, 2000.

                              VASOMEDICAL, INC.
                              By: /s/ D. Michael Deignan
                              --------------------------------------------
                              D. Michael Deignan, President and Chief Executive
                              Officer and Director (Principal Executive Officer)

                                POWER OF ATTORNEY

      KNOW ALL MEN BY THESE PRESENTS,  that each person whose signature  appears
below  constitutes and appoints D. Michael Deignan and Joseph A. Giacalone,  and
each of them, his true and lawful  attorneys-in-fact and agents, with full power
of substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to sign any and all amendments (including post-effective
amendments)  to this  Registration  Statement  and to file  the  same,  with all
exhibits  thereto,  and  other  documents  in  connection  therewith,  with  the
Securities and Exchange  Commission,  granting unto said  attorneys-in-fact  and
agents,  and each of them,  full power and  authority to do and perform each and
every act and thing  requisite and necessary to be done, as fully to all intents
and purposes as he might or could do in person,  hereby ratifying and confirming
all that  said  attorneys-in-fact  and  agents  or any of them,  or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

      In accordance  with the  requirements  of the Securities Act of 1933, this
registration  statement  was signed by the following  persons in the  capacities
indicated on July 31, 2000.

         Signatures                            Title
         ----------                            -----

-----------------------------           Director
Alexander G. Bearn

/s/ David S. Blumenthal                 Director
-----------------------------
David S. Blumenthal

/s/ Abraham E. Cohen                    Chairman of the Board
-----------------------------
Abraham E. Cohen

/s/ D. Michael Deignan
-----------------------------           President, Chief Executive Officer and
D. Michael Deignan                      Director (Principal Executive Officer)

/s/ Joseph A. Giacalone
-----------------------------           Secretary and Chief Financial Officer
Joseph A. Giacalone                     (Principal Financial and Accounting
                                        Officer)

/s/ John C.K. Hui                       Director
-----------------------------
John C. K. Hui

-----------------------------           Director
Photios T. Paulson

/s/ Kenneth W. Rind                     Director
-----------------------------
Kenneth W. Rind

/s/ E. Donald Shapiro                   Director
-----------------------------
E. Donald Shapiro

/s/ Anthony Viscusi                     Director
-----------------------------
Anthony Viscusi

/s/ Forrest R. Whittaker                Director
-----------------------------
Forrest R. Whittaker

/s/ Zhen-sheng Zheng                    Director
-----------------------------
Zhen-sheng Zheng
SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                Vasomedical, Inc.

                         Form S-8 Registration Statement

                             E X H I B I T  I N D E X

                                                      Page No. in Sequential
Exhibit                                               Numbering of all Pages,
Number              Exhibit Description               including Exhibit Pages
------------------------------------------------------------------------------

4             1999 Stock Option Plan, as amended

5             Opinion and Consent of Counsel

23.1          Consent of Counsel                        See Exhibit 5

23.2          Consent of Grant Thornton LLP

24            Power of Attorney                         See signature page